By Dr. William Kohlbrenner, CSO, LSN
With summer now behind us, the world’s biotech and medtech community is counting down to the San Francisco healthcare conference season. If you’re making your JPM plans now, it’s definitely time to apply to the RESI Innovation Challenge.
LSN’s scientific team is preparing to review the RESI Innovation Challenge applications from biotech, medtech, diagnostic and healthcare IT companies. Successful applicants will be provided with an all-day display space for their startup company at RESI – and with the heavy foot traffic at JPM, there’s never been a better opportunity to win investor exposure for your new technology. All applicants are vetted by LSN’s scientific review team, with a view to not just the quality of the company’s scientific work, but also the strength of the management team and how well-positioned the company is to receive investment.
On January 10th, all RESI attendees will have the opportunity to vote on the 30 Innovation Challenge finalists. See below for the past winners – a diverse group of startups from every area of the life sciences.
What makes the RESI Innovation Challenge so valuable? We’ve included a few words from previously successful participants below, but in short, being part of the Innovation Challenge provides startups with a new way to get attention and start dialogues with the investors who attend RESI. Participants can share their message all day in the exhibit hall, with their Innovation Challenge display providing a starting point for a meaningful conversation about the opportunity.
Here is what our previous winners are saying about the RESI Innovation Challenge:
“I love the RESI Innovation Challenge because it is a great way to give our pitch to practice it and try to obtain a scarce resource from these investors. Practicing with these investors is a great way to build relationships and continue that on to the real investment conversations.”
– Niko Skievaski, Co-Founder, Redox
1st Place, RESI@TMCx, June 8, 2015
“The RESI Innovation Challenge is a really good opportunity to meet investors and other companies in the space. It’s a good showcase to reach that audience.”
– Jessica Ching, CEO, Eve Medical
2nd Place, RESI San Francisco, January 12, 2016
“The RESI Innovation Challenge is a unique way to pitch, and provides a great opportunity to see what other companies are doing in the industry, while allowing you to meet with potential investors and strategic partners outside of the partnering meetings.”
– John Connolly, VP Corporate Development, Rna Diagnostics
1st Place, RESI Boston, September 16, 2015
“RESI offers small companies like GeneSegues a direct line to potential partners and potential investors in a small setting conducive to relationship building and conversation. The Innovation Challenge was a particularly great way to introduce our company to a broader audience than I could meet with personally which allowed us to leverage the showcasing of our technology more efficiently.”
-Laura M. Brod，Chief Executive Officer，GeneSegues Therapeutics
-1st Place, RESI @TMCx, April 11, 2016
Previous RESI Innovation Challenge 1st place winners include:
- BioMedomics, Inc. (Durham, NC, USA)
- Perimeter (Toronto, Canada)
- GeneSegues Therapeutics (Chaska, MN)
- Clearsight (Aurora, CO)
- Rna Diagnostics(Toronto, ON)
- Redox(Madison, WI)
- Empiriko(Newton, MA)
- ORIG3N(Boston, MA)
- Kineta(Seattle, WA)
You’ll be redirected to the application page. Please fill out this form as completely as possible. The application process takes approximately 15 minutes. If it will take you more than 30 minutes to fill out the form, please download the application form here: https://goo.gl/09TuE9 and send it to resi@lifesciencenation.com. Note: There is no fee to apply.
Next Phase Newsletter 